Piper Sandler Reaffirms “Neutral” Rating for Biogen (NASDAQ:BIIB)
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper ...
Biogen (NASDAQ:BIIB) Price Target Lowered to $241.00 at HC Wainwright
Biogen (NASDAQ:BIIB – Free Report) had its price target trimmed by HC Wainwright from $300.00 to $241.00 in a report issued ...
Biogen (NASDAQ:BIIB) Price Target Cut to $210.00 by Analysts at Truist Financial
Biogen (NASDAQ:BIIB – Free Report) had its target price lowered by Truist Financial from $220.00 to $210.00 in a research ...
BMO Capital Markets Cuts Biogen (NASDAQ:BIIB) Price Target to $139.00
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
Biogen (NASDAQ:BIIB) Price Target Cut to $265.00 by Analysts at Canaccord Genuity Group
Biogen (NASDAQ:BIIB – Get Free Report) had its target price lowered by equities researchers at Canaccord Genuity Group from ...
Biogen (NASDAQ:BIIB) Given Hold Rating at Needham & Company LLC
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & ...
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Savant Capital LLC
Savant Capital LLC raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,179 shares of the biotechnology company ...
Q1 Earnings Estimate for Biogen Issued By Leerink Partnrs
Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Biogen in a research note ...
Research Analysts Issue Forecasts for Biogen Q1 Earnings
Stock analysts at William Blair increased their Q1 2025 earnings per share (EPS) estimates for shares of Biogen in a research ...
Equities Analysts Issue Forecasts for Biogen FY2025 Earnings
Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note issued on Thursday, February 13th. Cantor Fitzgerald analyst E. Schmidt now ...
Choreo LLC Has $205,000 Stock Position in Biogen Inc. (NASDAQ:BIIB)
Choreo LLC cut its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 23.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange ...